• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION RANGER SL; CATHETER, PERCUTANEOUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION RANGER SL; CATHETER, PERCUTANEOUS Back to Search Results
Model Number 1584-01
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Restenosis (4576)
Event Date 03/02/2023
Event Type  Injury  
Manufacturer Narrative
A1: patient identifier: (b)(6).A2: age at time of event: 83 years old at the time of study enrollment.
 
Event Description
Elegance clinical trial it was reported that restenosis occurred.The subject underwent treatment with the ranger drug coated balloons on 15-jun-2022 as a part of the elegance clinical trial.The target lesion was in the right anterior tibial artery with 3.5 mm proximal reference vessel diameter and 2 mm distal reference vessel diameter with lesion length 320 mm with 100% stenosis and was classified as tasc ii c lesion.Prior to the target lesion treatment with the study device, pre-dilation was performed using 2 mm x 150 mm coyote pta balloon.Treatment of target lesion was performed by dilation using study devices, 2.5 mm x 120 mm, 3 mm x 120 mm and 3.5 mm x 150 mm ranger drug coated balloons.Following treatment, the final residual stenosis was noted to be 15%.On the (b)(6) 2022, the subject was discharged from the hospital on dual antiplatelet therapy.On 02-mar-2023, subject was noted with symptoms related to restenosis of right anterior tibial artery and was hospitalized for further evaluation and treatment.On 03-mar-2023, 261 days post index procedure, 70% stenosis noted in the right anterior tibial artery was treated with balloon dilation using coyote pta balloon.Post treatment, the final residual stenosis was noted to be 0%.On the same day, the event was considered to be resolved and on (b)(6) 2023, the subject was discharged from the hospital.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RANGER SL
Type of Device
CATHETER, PERCUTANEOUS
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
HEMOTEQ AG
adenauerstrasse 15
wuerselen 52146
GM   52146
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key18366147
MDR Text Key331010165
Report Number2124215-2023-72167
Device Sequence Number1
Product Code ONU
Combination Product (y/n)Y
Reporter Country CodeGM
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Study,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 12/20/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date11/18/2023
Device Model Number1584-01
Device Catalogue Number1584-01
Device Lot Number07316H21
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/28/2023
Initial Date FDA Received12/20/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/18/2021
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient SexFemale
Patient RaceWhite
-
-